A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a perpetual dispute
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer. Myths, facts and new data on a perpetual dispute
Authors
Keywords
-
Journal
International Braz J Urol
Volume 40, Issue 1, Pages 3-15
Publisher
FapUNIFESP (SciELO)
Online
2017-03-09
DOI
10.1590/s1677-5538.ibju.2014.01.02
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials
- (2013) Saroj Niraula et al. JOURNAL OF CLINICAL ONCOLOGY
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- (2013) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial
- (2012) Nicolas Mottet et al. BJU INTERNATIONAL
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects
- (2012) Arto J. Salonen et al. EUROPEAN UROLOGY
- Safety and tolerability of intermittent androgen deprivation therapy: A literature review
- (2012) Damian Gruca et al. INTERNATIONAL JOURNAL OF UROLOGY
- The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
- (2012) Arto J. Salonen et al. JOURNAL OF UROLOGY
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- (2012) Juanita M. Crook et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study
- (2011) J E Ward et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery
- (2011) Alessandro Sciarra et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer
- (2011) Johan F. Langenhuijsen et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An update on androgen deprivation therapy for prostate cancer
- (2010) Nima Sharifi et al. ENDOCRINE-RELATED CANCER
- Duration of First Off-Treatment Interval Is Prognostic for Time to Castration Resistance and Death in Men With Biochemical Relapse of Prostate Cancer Treated on a Prospective Trial of Intermittent Androgen Deprivation
- (2010) Evan Y. Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study
- (2009) Nigel A. Spry et al. BJU INTERNATIONAL
- Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?
- (2009) Massimo Perachino et al. BJU INTERNATIONAL
- Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group
- (2009) Fernando E.C. Calais da Silva et al. EUROPEAN UROLOGY
- Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2009) Per-Anders Abrahamsson EUROPEAN UROLOGY
- A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation
- (2009) William D. Figg et al. JOURNAL OF UROLOGY
- QUALITY OF LIFE EFFECTS OF INTERMITTENT AND CONTINUOUS HORMONAL THERAPY BY CYPROTERONE ACETATE (CPA) FOR METASTATIC PROSTATE CANCER
- (2008) P.C.M.S. Verhagen et al. EUROPEAN UROLOGY SUPPLEMENTS
- Finnish Multicenter Study Comparing Intermittent to Continuous Androgen Deprivation for Advanced Prostate Cancer: Interim Analysis of Prognostic Markers Affecting Initial Response to Androgen Deprivation
- (2008) Arto J. Salonen et al. JOURNAL OF UROLOGY
- International epidemiology of prostate cancer: Geographical distribution and secular trends
- (2008) Peter D. Baade et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Etoricoxib and Intermittent Androgen Deprivation Therapy in Patients with Biochemical Progression After Radical Prostatectomy
- (2008) Franco Di Silverio et al. UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started